Effects of PAHs exposure on peripheral blood H19 RNA expressions and plasma SAHH activity among 146 occupational workers
Table 1 summarizes the basic characteristics of study population based on the quartiles of urinary 1-OHP concentrations. There were no significant differences in age, smoking status, drinking status, heating mode, education (P > 0.05); even so, the marginal significances were showed in employment time (P = 0.053). The results indicated that with the rise of urinary 1-OHP levels, the concentrations of urinary 2-NAP, 2-FLU, 9-PHE and ΣOH-PAHs metabolites were also significantly elevated (P < 0.001). In addition, the detailed distributions of peripheral blood H19 RNA expressions and plasma SAHH activity were given in Fig. 1A with violin plots. An elevated median of peripheral blood H19 RNA expressions was showed coupled with the increased quartile of urinary 1-OHP levels (P = 0.479), whereas the median of plasma SAHH activity was slightly reduced (P = 0.844). These findings are consistent with our previous experiments in human lung-derived cells treated with BaP (4).
Table 1
Basic characteristics of participants by urinary 1-OHP among 146 occupational workers a
Variable | Urinary 1-OHP (µg/mmol creatinine) | P value b |
Total (n = 146) | Quartile 1 (< 0.03) (n = 36) | Quartile 2 (0.03–0.06) (n = 36) | Quartile 3 (0.06–0.11) (n = 37) | Quartile 4 (> 0.11) (n = 37) |
General characteristic | | | | | | |
Age (years) | 40.5 (10) | 39.5 (9) | 44.0 (11) | 43.0 (10) | 39.0 (12) | 0.144 |
Employment time (years) | 21.0 (12) | 20.0 (12) | 26.5 (13) | 24.0 (10) | 19.0 (17) | 0.053 |
Smoking | 105 (71.9) | 26 (72.2) | 27 (75.0) | 27 (73.0) | 25 (67.6) | 0.910 |
Drinking | 73 (50.0) | 18 (50.0) | 15 (41.7) | 20 (54.1) | 20 (54.1) | 0.685 |
Central heating | 140 (95.9) | 33 (91.7) | 36 (100.0) | 35 (94.6) | 36 (97.3) | 0.319 |
Education (years) | | | | | | 0.367 |
≤ 9 | 41 (28.1) | 10 (27.8) | 13 (36.1) | 6 (16.2) | 12 (32.4) |
10–12 | 57 (39.0) | 12 (33.3) | 14 (38.9) | 15 (40.5) | 16 (43.2) |
> 12 | 48 (32.9) | 14 (38.9) | 9 (25.0) | 16 (43.2) | 9 (24.3) |
PAHs internal exposure biomarker | | | | | | |
2-NAP | 0.74 (0.77) | 0.62 (0.71) | 0.70 (0.50) | 0.53 (0.58) | 1.13 (1.43) | 0.001 |
2-FLU | 0.29 (0.27) | 0.18 (0.13) | 0.27 (0.17) | 0.25 (0.29) | 0.53 (0.63) | < 0.001 |
9-PHE | 0.09 (0.09) | 0.06 (0.03) | 0.07 (0.04) | 0.09 (0.07) | 0.23 (0.22) | < 0.001 |
ΣOH-PAHs | 0.32 (0.29) | 0.23 (0.18) | 0.27 (0.20) | 0.32 (0.20) | 0.51 (0.56) | < 0.001 |
Concentration unit of 2-NAP, 2-FLU, 9-PHE and 1-OHP is µg/mmol creatinine. |
a Data were presented as N (%) or Med (IQR). |
b P-values were calculated from Chi-square test for categorical variables and Kruskal-Wallis H test for numerical variables. |
The results of collinearity diagnostics showed that there was no collinearity between the four urinary PAHs metabolites, and also indicated that age was not collinear with employment time (Table S3). Figure 1C represented that peripheral blood H19 RNA expressions were significantly increased when 1-OHP levels were lower than 0.09 µg/mM creatinine, and then maintained on the plateau phase while there is a marginal positive linear association between urinary 1-OHP levels and peripheral blood H19 RNA expressions (4th vs. 1st quartile = 3.44, 95% CI: 1.04–11.44, P trend =0.058) (Fig. 1B). Nevertheless, the plasma SAHH activity was significantly reduced when 1-OHP levels were lower than 0.06 µg/mM creatinine (Fig. 1C), showing a non-linear association between plasma SAHH activity and urinary 1-OHP concentrations (P overall = 0.089, P non-linearity = 0.030) (Fig. 1C). However, the results did not reveal that 2-NAP, 9-PHE, 2-FLU and ΣOH-PAHs metabolites have significant effects on the expression of H19 RNA in peripheral blood and plasma SAHH activity (P > 0.05, Table S4).
H19 interacts with SAHH at specific sites and then regulates DNMT1 in BEAS-2B cells exposed to BaP
Previous results have established that H19 interacts with and suppresses SAHH expressions and activity would be enhanced by BaP (4), we performed RIP experiments using four types SAHH-overexpressing (WT-SAHH, M1-SAHH, M2-SAHH and M3-SAHH) cells to illuminate the binding sites between SAHH and H19. Whether exposed BaP or not, we observed an accessorial enrichment of H19 in SAHH-containing complexes in WT-SAHH, M1-SAHH and M2-SAHH cells (Fig. 2A), whereas M3-SAHH cells did not detectably elevate (Fig. 2A, left column 5 & right column 5). After BaP exposure, H19 RNA expressions were inhibited in SAHH-overexpressing cells compare to WT cells (Fig. 2B, right column 3–6), particularly in M3-SAHH cells (Fig. 2B, right column 5). These results reveal that H19 may bind to the 1–300 amino acid chain instead of 300–432 amino acid chain of SAHH.
To better understand which DNMTs is most affected by H19 and SAHH, five types (WT, si-NC, si-H19, si-SAHH, si-H19 + si-SAHH) cells were used to the further experiments (Fig. 2C & 2D). The exaggerated expression (Fig. 2C, right column) and activity (Fig. 2D, right) of DNMT1 were observed in WT cells exposed to BaP, whereas a significant decrease in si-H19, si-SAHH and si-H19 + si-SAHH cells exposed to BaP was observed (Fig. 2C; Fig. 2D). Collectively, these results revealed that H19 binding to SAHH was more likely affected DNMT1 expressions and activity after BaP treatment.
H19 binding to SAHH interacts with DNMT1 in BEAS-2B cells exposed to BaP
As H19 interacts with SAHH and shows characteristics of a ribonucleoprotein particle (4), we reasoned that H19 binding to SAHH interacts with DNMT1 in BEAS-2B cells treated with BaP. In support of the assumption, we accessed Co-IP experiments to examine whether anti-DNMT1 antibody would be able to immunoprecipitate SAHH from complex. As shown in Fig. 3A, Co-IP analysis showed that a nearly 0.5-fold enrichment of SAHH in the DNMT1 antibody complex compared with WT cells. In addition, compared with the WT and si-NC cells, SAHH protein expression in si-H19 cells was significantly increased after BaP exposure (Fig. 3A, right column 3). However, the enrichment of SAHH in DNMT1-containing complex between WT and si-NC cells was similar (Fig. 3A, left column 2 & right column 2).
Additionally, co-localization between endogenous H19, SAHH and DNMT1 was evaluated by confocal microscopy, predominantly in nucleus and perinuclear cytoplasm (Fig. 3B, white arrow). We found that the fluorescence intensity of DNMT1 was increased after BaP exposure for 24 hours (Fig. 3B, column 4). The intracellular co-localization of H19 and SAHH was consistent with the previous results (Fig. 3B, column 5). The increased fluorescence of purple intensity, which displayed the intracellular co-localization of H19 and DNMT1, indicated a stronger steric interaction after BaP exposure for 24 hours, while fluorescence intensity was decreased in si-H19 cells (Fig. 3B, column 6). In addition, the increased fluorescence intensity of SAHH and DNMT1 indicated a stronger steric interaction after BaP exposure for 24 hours and transfected with si-H19 (Fig. 3B, column 7). Moreover, we also observed the increased fluorescence of blue violet, which displayed the intracellular co-localization of H19, SAHH and DNMT1, indicated a stronger steric interaction after BaP exposure for 24 hours (Fig. 3B, column 8). Together, these results suggest that H19 binding to SAHH interacts with DNMT1 in BEAS-2B cells treated with BaP.
H19 /SAHH/DNMT1 regulates OGG1 methylation
In order to test that H19 binding to SAHH might interfere with DNMT1 and then regulate gene methylation in BaP-treated cells, we used eight type cells (WT, si-H19, si-SAHH, si-DNMT1, si-H19 + si-SAHH, si-H19 + si-DNMT1, si-SAHH + si-DNMT1, and si-NC) for BaP treatment. Pearson's correlation tests between methylation values (% 5-mC) each CpG locus in the first exon of OGG1 and mean methylation value of four loci reveal high correlations (Pearson's r ranged from 0.63 to 0.86) (Fig. 4A). Results indicated that after BaP exposure, the levels of OGG1 methylation in BEAS-2B cells increased significantly (Fig. 4B), whereas that in si-H19 cells decreased (Fig. 4B, right column 3). Conversely, SAHH or DNMT1 single knockdown exacerbated OGG1 methylation (Fig. 4B, right column 4 & 5) and SAHH/DNMT double knockdown markedly aggravated the alteration (Fig. 4B, right column 8). Interestingly, although H19 single knockdown obviously reduced OGG1 methylation, H19/SAHH and H19/DNMT1 double knockdown abolished this effect (Fig. 4B, right column 6). However, similar changes in OGG1 methylation were observed in WT and si-NC cells (Fig. 4B, right column 2). Collectively, we concluded that H19/SAHH/DNMT1 regulates OGG1 methylation in BEAS-2B cells treated with BaP.
H19 /SAHH/DNMT1 affects oxidative DNA damage and cell cycle arrest
Given the previous study conducted by our team indicating that OGG1 methylation mediated oxidative DNA damage and cell cycle arrest associated with urinary 1-OHP concentrations in coke oven workers (13), we took an in vitro approach to examine whether H19/SAHH/DNMT1would regulate oxidative DNA damage and cell cycle arrest in accordance with the alteration of OGG1 methylation for BaP exposure. Figure 4C & 4D exhibited the effects H19/SAHH/DNMT1 on the oxidative DNA damage and cell cycle arrest. After transfection, there was no significant change in the levels of 8-OHdG compared with WT cells (Fig. 4C, left column). However, the 8-OHdG levels were significantly increased in cells treated with BaP (Fig. 4C, right column). After BaP exposure, H19 single knockdown slightly reduced 8-OHdG levels (Fig. 4C, right column 3), whereas SAHH or DNMT1 single knockdown significantly elevated 8-OHdG levels (Fig. 4C, right column 4 & 5). After BaP treatment, SAHH/DNMT1 double knockdown further dramatically increased 8-OHdG levels (Fig. 4C, right column 8), whereas H19/SAHH and H19/DNMT1 double knockdown abrogated this effect (Fig. 4C, right column 6 & 7). Furthermore, the results of S phase arrest were parallel to 8-OHdG levels (Fig. 4D). Combined with our previous findings (13) and in vitro data (Fig. 4B), these results strongly support that H19/SAHH/DNMT1would regulate oxidative DNA damage and cell cycle arrest in BEAS-2B cells treated with BaP in keeping with OGG1 methylation alterations.